Moreover, cell line experiments revealed that B4GALNT3 expression regulates cancer stemness and the invasive properties of colon cancer cells through modifying epidermal growth factor receptor (EGFR) glycosylation and downstream signaling (Table 1) [83]. The gene discussed is EGFR; the disease is colonic neoplasm.